16 June 2026·PIB

PCIM&H Represents India at 5th WHO Expert Meeting on International Herbal Pharmacopoeia

In this note

1. At a Glance

PCIM&H (Pharmacopoeia Commission for Indian Medicine & Homoeopathy), a subordinate office of the Ministry of Ayush, is representing India at the 5th WHO Expert Meeting on the Development of the International Herbal Pharmacopoeia (IHP) in Hong Kong SAR, 16–18 June 2026 [1][3].
Relevance: intersection of traditional medicine standardisation, WHO multilateral standards, India's Ayush diplomacy and the upcoming WHO Global Traditional Medicine Centre at Jamnagar [4][5].

The 5th WHO Expert Meeting on IHP convened in Hong Kong SAR, China, 16–18 June 2026 [1].
India represented by Dr. Raman Mohan Singh, Director, PCIM&H, as expert member; a technical team (PSOs/SOs in Pharmacognosy, Ayurveda, Chemistry, Siddha) joined virtually [1].

PCIM&H approved by Union Cabinet as a Subordinate Office under Ministry of Ayush; gazette of merger dated 6 July 2020, merging the erstwhile PCIM&H with PLIM (Pharmacopoeial Laboratory for Indian Medicine), Ghaziabad and HPL (Homoeopathic Pharmacopoeia Laboratory) [2][3].
Mandate: develop Pharmacopoeial Standards for ASU&H (Ayurveda, Siddha, Unani & Homoeopathy) drugs; functions as Central Drug Testing-cum-Appellate Laboratory for Indian Systems of Medicine [3].
WHO IHP work runs alongside WHO-IRCH (International Regulatory Cooperation for Herbal Medicines); India has hosted WHO–IRCH workshops at PCIM&H, Ghaziabad [6][4].

Parent Ministry: Ministry of Ayush, Government of India [1][3].
PCIM&H HQ: Ghaziabad, Uttar Pradesh [6].
Created by: Cabinet approval, gazette 6 July 2020 (merger of three legacy bodies) [2].
Director (2026): Dr. Raman Mohan Singh [1].
WHO programme owner: WHO Department of Health Product Policy and Standards (norms & standards for pharmaceuticals) [5].
Allied WHO mechanism: WHO-IRCH, with its 16th Annual Meeting held in Jakarta, Indonesia (2025) hosted by BPOM [4].
2nd WHO Traditional Medicine Global Summit: 17–19 December 2025, New Delhi [4].
ISO certifications held by PCIM&H: ISO 9001:2015 (QMS), ISO 14001:2015 (EMS), ISO 45001:2018 (OH&S) [3].

Scientific / Technological: IHP develops monographs (quality/identity/purity specs) for medicinal plants — pharmacognosy, chromatographic fingerprinting, heavy-metal/pesticide limits [5].
Geopolitical / Strategic: Standard-setting at WHO is a soft-power lever; India leverages Ayush and the WHO Global Traditional Medicine Centre, Jamnagar to embed Indian classical formulations into global norms [4].
Economic: Harmonised global standards reduce non-tariff barriers for India's AYUSH exports (botanicals, herbal extracts) [3].
Legal / Regulatory: Standards published feed into Drugs & Cosmetics Act, 1940 Schedules and IRCH regulatory convergence [6].
Administrative: PCIM&H acts as the technical secretariat for Ayurvedic Pharmacopoeia of India (API), Unani Pharmacopoeia of India (UPI), Siddha Pharmacopoeia of India (SPI) and Homoeopathic Pharmacopoeia of India (HPI) [3].

16–18 June 2026: 5th WHO IHP Expert Meeting, Hong Kong SAR; India's PCIM&H delegation participates [1].
29 October 2025: 16th WHO-IRCH annual meeting, Jakarta — IHP progress and Global Traditional Medicine Strategy 2025–2034 discussed [4].
17–19 December 2025: 2nd WHO Traditional Medicine Global Summit, New Delhi [4].
2025: PCIM&H hosted WHO-IRCH International Workshop at Ghaziabad [6].
2024–25: PCIM&H earned BIS-IMS / ISO 9001-14001-45001 certifications [3].

PCIM&H is a subordinate office under Ministry of Ayush (not autonomous body) [2].
PCIM&H was constituted by merger of three bodies with gazette dated 6 July 2020 [2].
5th WHO IHP Expert Meeting venue: Hong Kong SAR, China [1].
IHP = International Herbal Pharmacopoeia, a WHO publication of quality-control specs for medicinal plants [5].
WHO-IRCH = International Regulatory Cooperation for Herbal Medicines [4].
WHO Global Traditional Medicine Centre is at Jamnagar, Gujarat [4].
2nd WHO Traditional Medicine Global Summit: New Delhi, December 2025 [4].
PCIM&H headquarters: Ghaziabad, UP, co-located with erstwhile PLIM [6].
PCIM&H publishes API, UPI, SPI, HPI pharmacopoeias [3].
India represented as expert member by Director, PCIM&H [1].

GS-II: Important International Institutions (WHO); Bilateral/multilateral groupings; Health governance.
GS-III: Science & Technology indigenisation; IPR and traditional knowledge; Indian economy — exports of botanicals.
Question stems: 1. "Discuss how India's leadership in traditional medicine standard-setting at WHO advances both public health and trade objectives." 2. "Examine the role of the Ministry of Ayush institutions in integrating Indian Systems of Medicine with global pharmacopoeial frameworks." 3. "The WHO Global Traditional Medicine Centre at Jamnagar marks a soft-power inflection for India. Critically analyse."

WHO Global Traditional Medicine Centre, Jamnagar — flagship India-WHO institution.
Ayurvedic Pharmacopoeia of India (API) — domestic counterpart of IHP.
WHO-IRCH — regulatory cooperation network for herbal medicines.
Drugs & Cosmetics Act, 1940 — Schedule T / ASU&H provisions — statutory base for Ayush quality.
Traditional Knowledge Digital Library (TKDL) — IPR defence for Indian medicinal knowledge.
National AYUSH Mission (NAM) — CSS for ASU&H sector development.
WHO Global Traditional Medicine Strategy 2025–2034 — policy umbrella.
Nagoya Protocol & Biological Diversity Act, 2002 — access & benefit sharing for medicinal plants.

PCIM&H is under Ministry of Ayush, not Ministry of Health & Family Welfare.
IHP (International Herbal Pharmacopoeia) ≠ International Pharmacopoeia (Ph. Int.) — the latter covers all medicines; IHP is specifically herbal [5].
PCIM&H is a subordinate office, not a statutory commission or autonomous body.
WHO GTMC is at Jamnagar (Gujarat), not Ghaziabad (PCIM&H HQ).
The 5th meeting was hosted in Hong Kong SAR, not WHO Geneva HQ.